Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer: a Prospective Open-label Single-arm Clinical Trial

NCT04972682 is registered in ClinicalTrials.gov with Moscow City Oncology Hospital No. 62 as lead sponsor.

NCT NCT04972682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04972682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer: a Prospective Open-label Single-arm Clinical Trial
Lead sponsor
Moscow City Oncology Hospital No. 62
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2021
Completion date
April 15, 2024
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial adenocarcinoma, endometrial cancer, endometrial cancer stage i, endometrial cancer stage ii, endometrial endometrioid adenocarcinoma, endometrial neoplasms, hysterectomy, laparoscopic hysterectomy, sentinel lymph node